Genetic Testing and Screening Guidelines for BRCA1/2-Positive Individuals

Age Recommendations for Genetic Testing

The American Society of Clinical Oncology recommends that genetic testing for BRCA1/2 mutations should generally be deferred until children reach adulthood, typically age 25 years, when medical management becomes actionable 1
The National Comprehensive Cancer Network suggests that legal adulthood (age 18) may be considered as an alternative starting point for genetic testing, though medical interventions typically begin at age 25 1
Genetic counseling should be provided before testing to discuss benefits, risks, and implications for the patient and family, as recommended by the National Comprehensive Cancer Network 2

The European Society for Medical Oncology guidelines recommend that breast awareness training and monthly self-examination should start at age 18, and clinical breast examination every 6-12 months beginning at age 25 3
The National Comprehensive Cancer Network recommends annual breast MRI with contrast starting at age 25-29, and mammography only if MRI is unavailable during this age range 3, 4
For BRCA1/2-positive individuals aged 30-75, the National Comprehensive Cancer Network recommends annual mammogram and breast MRI with contrast, and clinical breast examination every 6-12 months 3
The European Society for Medical Oncology guidelines suggest that BRCA1 carriers may benefit from 6-monthly MRI screening due to rapid growth rates of BRCA1-associated breast cancers 1

The National Comprehensive Cancer Network recommends that pre-testing counseling should include psychosocial assessment and support, risk counseling and education about hereditary cancer syndromes, and discussion of genetic testing implications and informed consent 5
The American Society of Clinical Oncology suggests that discussion of implications for family members and cascade testing should be included in pre-testing counseling 1, 2

The National Comprehensive Cancer Network recommends that screening should begin 5 years before the youngest affected family member, or at age 30 at the latest, to avoid delayed screening for high-risk individuals 1
Using mammography alone in young BRCA carriers (ages 25-29) is inadequate, and MRI demonstrates significantly higher sensitivity compared to mammography in this population, as recommended by the National Comprehensive Cancer Network 3